Skip to main content

Advertisement

Log in

Tobacco Use: A Chronic Illness?

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Tobacco use is a modifiable risk factor that has many characteristics of a chronic illness. We analyzed longitudinal data from participants in the Atherosclerosis Risk in Communities Study (ARIC) and the Cardiovascular Health Study (CHS) and compared tobacco use to other chronic illnesses to evaluate effects on mortality. We limited our analysis to 20,293 participants aged 45 and older at baseline. We determined smoking status, diabetes status, hypertension, cardiovascular disease (ASCVD), and lung disease status at baseline. We developed Cox proportional hazard models, adjusting for age, sex and race and all comorbid diseases, to determine the effect of disease on mortality at up to 13 years of follow-up, 3,022 study participants died during the follow-up period. Adjusted proportional hazard models found that the risk of smoking for death had a hazard ratio (HR) of 2.0 (95% confidence interval [CI] 1.8, 2.2). This was similar to the mortality risk for ASCVD (HR 1.8, 95% CI 1.7, 2.0), diabetes (HR 1.9, 95% CI 1.7, 2.0), and chronic obstructive pulmonary disease (COPD) (HR 2.1, 95% CI 1.9, 2.4). The risk in former smokers were significantly less than that of current smokers (HR 1.1, 95% CI 1.01, 1.2). In the adjusted models, current cigarette smoking has a mortality risk that is in the same range of that seen in other “chronic diseases”, whereas the risk in former smokers is greatly reduced. These data suggest that current smoking should be approached as aggressively as other chronic diseases that are amenable to interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Centers for Disease Control and Prevention. (2004). Indicators for chronic disease surveillance. MMWR Recommendations and Reports, 53, 1–6.

    Google Scholar 

  2. Lee, C., & Kahende, J. (2007). Factors associated with successful smoking cessation in the United States, 2000. American Journal of Public Health, 97, 1503–1509.

    Article  PubMed  Google Scholar 

  3. American Heart Association. (2007). Cardiovascular disease statistics. American Heart Association. http://www.americanheart.org/presenter.jhtml?identifier=4478.

  4. Fiore, M. C., Croyle, R. T., Curry, S. J., Cutler, C. M., Davis, R. M., Gordon, C., et al. (2004). Preventing 3 million premature deaths and helping 5 million smokers quit: A national action plan for tobacco cessation. American Journal of Public Health, 94, 205–210.

    Article  PubMed  Google Scholar 

  5. American Cancer Society. (2007). Prevention and early detection: Cigarette smoking. American Cancer Society. http://www.cancer.org/docroot/PED/content/PED_10_2x_cigarette_smoking.asp.

  6. Enright, P. L., Kronmal, R. A., Higgins, M. W., Schenker, M. B., & Haponik, E. F. (1994). Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular health study. Chest, 106, 827–834.

    Article  CAS  PubMed  Google Scholar 

  7. Gritz, E. R., Vidrine, D. J., & Fingeret, M. C. (2007). Smoking cessation a critical component of medical management in chronic disease populations. American Journal of Preventive Medicine, 33, S414–S422.

    Article  PubMed  Google Scholar 

  8. Li, R., Folsom, A., Sharrett, A. R., Couper, D., Bray, M., & Tyroler, H. A. (2001). Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: The atherosclerosis risk in communities (ARIC) study. Atherosclerosis, 154, 729–738.

    Article  CAS  PubMed  Google Scholar 

  9. Wattanakit, K., Folsom, A. R., Chambless, L. E., & Nieto, F. J. (2005). Risk factors for cardiovascular event recurrence in the atherosclerosis risk in communities (ARIC) study. American Heart Journal, 149, 606–612.

    Article  PubMed  Google Scholar 

  10. Kaur, J., Singh, P., & Sowers, J. R. (2002). Diabetes and cardiovascular disease. American Journal of Therapeutics, 9, 510–515.

    Article  PubMed  Google Scholar 

  11. Kuller, L. H., Velentgas, P., Barzilay, J., Beauchamp, N. J., O’Leary, D. H., & Savage, P. J. (2000). Diabetes mellitus: Subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 823–829.

    CAS  PubMed  Google Scholar 

  12. Anthonisen, N. R. (2005). The effects of a smoking cessation intervention on 14.5-year mortality—response. Annals of Internal Medicine, 143, 615.

    Google Scholar 

  13. Schroeder, E. B., Welch, V. L., Evans, G. W., & Heiss, G. (2005). Impaired lung function and subclinical atherosclerosis. The ARIC study. Atherosclerosis, 180, 367–373.

    Article  CAS  PubMed  Google Scholar 

  14. Mannino, D. M., Doherty, D. E., & Buist, A. S. (2006). Global initiative on obstructive lung disease (GOLD) classification of lung disease and mortality: Findings from the atherosclerosis risk in communities (ARIC) study. Respiratory Medicine, 100, 115–122.

    Article  PubMed  Google Scholar 

  15. Atherosclerosis risk in communities study: Community surveillance and cohort morbidity/mortality follow-up manual 1 general description and study management version 5.0. (2006).

  16. Atherosclerosis risk in communities study. University of North Carolina School of Public Health. (2008).

  17. Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 176, 532–555.

    Article  PubMed  Google Scholar 

  18. Rijken, M., van Kerkhof, M., Dekker, J., & Chellevis, F. G. (2005). Comorbidity of chronic diseases: Effects of disease pairs on physical and mental functioning. Quality of Life Research, 14, 45–55.

    Article  PubMed  Google Scholar 

  19. Li, R. L., Boerwinkle, E., Olshan, A. F., Chambless, L. E., Pankow, J. S., Tyroler, H. A., et al. (2000). Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis, 149, 451–462.

    Article  CAS  PubMed  Google Scholar 

  20. Khurana, S., Batra, V., Patkar, A. A., & Leone, F. T. (2003). Twenty-first century tobacco use: It is not just a risk factor anymore. Respiratory Medicine, 97, 295–301.

    Article  CAS  PubMed  Google Scholar 

  21. Olshan, A. F., Li, R., Pankow, J. S., Bray, M., Tyroler, H. A., Chambless, L. E., et al. (2003). Risk of atherosclerosis: Interaction of smoking and glutathione S-transferase genes. Epidemiology, 14, 321–327.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was funded by a research grant from Pfizer.

Disclosure Statement

Dr. Mannino has received research grants from GlaxoSmithKline, Pfizer, and Novartis and serves as a consultant to GlaxoSmithKline, Pfizer, Boehringer-Ingelheim, Astra-Zeneca, Dey, Sepracor, and Novartis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David M. Mannino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hudson, N.L., Mannino, D.M. Tobacco Use: A Chronic Illness?. J Community Health 35, 549–553 (2010). https://doi.org/10.1007/s10900-010-9241-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-010-9241-x

Keywords

Navigation